Jan Nilsson, CEO
Jan Nilsson was appointed CEO of CombiGene in October 2016. Jan has a vast experience both from large pharmaceutical companies and from biotech companies. Jan has been involved in many areas in the pharmaceutical industry spanning from early drug development to sales and marketing of established international brands. Jan has extensive leadership experience and has served as CEO both in public and in private companies.
Casper René Götzsche, CSO
Born in 1981, and PhD in Health and Medical Sciences in 2015 from University of Copenhagen. He has worked with NPY and gene therapy targeting brain diseases since 2008 and has authored more than 10 scientific papers related to the subject. Casper has previous been affiliated as guest researcher at Lund University and the reputable Massachusetts Institute of Technology (US).